Prolactin induced increase in neural stem cell numbers and therapeutical use thereof
CA 2460184 A1 · Owner: Stem Cell Therapeutics Inc. · Inventors: Weiss, Samuel; Shingo, Tetsuro
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using prolactin. The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used for example, for , transplantation treatment of patients or animals suffering from neurodegenerative diseases or conditions. In addition since neural stem cells , are a source for olfactory neurons the present invention also provides , methods of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 30, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 30, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 30, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.